Rx Oversight Issues at Federal Workers’ Comp Program Endangered Patients, Audit Says
Executive Summary
OWCP says that hiring a PBM will address overprescribing and cost concerns, but a consultant who participated in the audit is skeptical.
You may also be interested in...
Even As PBMs Face Reckoning, Formulary Exclusions Rise Again In 2023
Congressional scrutiny aside, ‘the rebate model remains alive and well’ as the big three pharmacy benefit managers exclude around 600 drugs each from their formularies.
AHIP, PhRMA Try to Control Narrative as Heat on PBMs Intensifies
As health insurance lobby launches advertising campaign to defend ‘evidence-based, market-driven tools,’ drug firms point out the connection between insurers and pharmacy benefit managers.